VR Logo

Aurobindo Pharma: Board to consider Q1 results & Interim Dividend on August 12 2020


Aurobindo Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 12 2020 inter alia to consider and approve the following:

1. Standalone & Consolidated Unaudited Financial Results of the Company for the first quarter ended June 30 2020 (Q1) and

2. Payment of Interim Dividend if any for the financial year 2020-21.

Further to earlier letter dated June 29 2020 informing the closure of Trading Window of the Company from July 01 2020 until 48 hours from the date of declaration of the Unaudited Financial Results of the Company for the first quarter ended June 30 2020 Company inform that the Trading Window will remain closed up to August 14 2020 and shall be re-opened on August 15 2020.

Click here to view PDF